Titre : Vaccins contre le SIDA

Vaccins contre le SIDA : Questions médicales fréquentes

Termes MeSH sélectionnés :

Influenza Vaccines

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment évaluer l'efficacité d'un vaccin contre le SIDA ?

L'efficacité est évaluée par des essais cliniques mesurant la réduction des infections.
Vaccins SIDA Essais cliniques
#2

Quels tests sont utilisés pour diagnostiquer le VIH ?

Les tests sérologiques et les tests d'acide nucléique détectent le VIH dans le sang.
VIH Tests de dépistage Diagnostic

Symptômes 2

#1

Quels sont les symptômes du VIH/SIDA ?

Les symptômes incluent fièvre, fatigue, éruptions cutanées et infections opportunistes.
SIDA Symptômes Infections opportunistes
#2

Le vaccin peut-il provoquer des symptômes ?

Des effets secondaires légers comme douleur au site d'injection peuvent survenir.
Vaccins Effets secondaires SIDA

Prévention 2

#1

Comment les vaccins contribuent-ils à la prévention du SIDA ?

Ils stimulent le système immunitaire pour prévenir l'infection par le VIH.
Prévention Vaccins SIDA
#2

Quelles autres méthodes préviennent le VIH ?

L'utilisation de préservatifs et la prophylaxie pré-exposition (PrEP) sont efficaces.
Prévention VIH PrEP

Traitements 2

#1

Les vaccins remplacent-ils les traitements antirétroviraux ?

Non, les vaccins complètent les traitements, mais ne les remplacent pas.
Traitements antirétroviraux Vaccins SIDA
#2

Quels traitements sont disponibles pour le VIH ?

Les traitements incluent les antirétroviraux qui contrôlent la charge virale.
VIH Antirétroviraux Traitements

Complications 2

#1

Quelles complications peuvent survenir sans vaccin ?

Sans vaccin, le risque d'infections opportunistes et de maladies graves augmente.
Complications SIDA Infections opportunistes
#2

Les vaccins peuvent-ils causer des complications ?

Des complications graves sont rares, mais des réactions allergiques peuvent survenir.
Vaccins Complications Réactions allergiques

Facteurs de risque 2

#1

Quels sont les facteurs de risque pour le VIH ?

Les rapports non protégés, le partage de seringues et les antécédents d'infections sont des risques.
Facteurs de risque VIH Comportements à risque
#2

Les vaccins réduisent-ils les facteurs de risque ?

Oui, en prévenant l'infection, les vaccins diminuent les comportements à risque associés.
Vaccins Prévention Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA : Questions médicales les plus fréquentes", "headline": "Vaccins contre le SIDA : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins contre le SIDA : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-01", "dateModified": "2024-12-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins antiviraux", "url": "https://recherchemedicale.com/mesh/D014765", "about": { "@type": "MedicalCondition", "name": "Vaccins antiviraux", "code": { "@type": "MedicalCode", "code": "D014765", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899" } } }, "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA", "alternateName": "AIDS Vaccines", "code": { "@type": "MedicalCode", "code": "D016915", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jianzhou Yang", "url": "https://recherchemedicale.com/author/Jianzhou%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Preventive Medicine, Changzhi Medical College, Changzhi, China." } }, { "@type": "Person", "name": "Xiangjun Zhang", "url": "https://recherchemedicale.com/author/Xiangjun%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Public Health, University of Tennessee, Knoxville, TN, United States." } }, { "@type": "Person", "name": "Xiaojie Huang", "url": "https://recherchemedicale.com/author/Xiaojie%20Huang", "affiliation": { "@type": "Organization", "name": "Beijing Youan Hospital, Capital Medical University, Beijing, China." } }, { "@type": "Person", "name": "Maohe Yu", "url": "https://recherchemedicale.com/author/Maohe%20Yu", "affiliation": { "@type": "Organization", "name": "Tianjin Centers for Disease Control and Prevention, Tianjin, China." } }, { "@type": "Person", "name": "Guanghua Lan", "url": "https://recherchemedicale.com/author/Guanghua%20Lan", "affiliation": { "@type": "Organization", "name": "Guangxi Center for Disease Prevention and Control, Nanning, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Global influenza vaccination rates and factors associated with influenza vaccination.", "datePublished": "2022-11-01", "url": "https://recherchemedicale.com/article/36328290", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijid.2022.10.038" } }, { "@type": "ScholarlyArticle", "name": "Association Between Influenza Vaccination During Pregnancy and Infant Influenza Vaccination.", "datePublished": "2023-01-16", "url": "https://recherchemedicale.com/article/36728080", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/AOG.0000000000005101" } }, { "@type": "ScholarlyArticle", "name": "Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate.", "datePublished": "2023-11-15", "url": "https://recherchemedicale.com/article/37964587", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2023.2266233" } }, { "@type": "ScholarlyArticle", "name": "Veteran influenza vaccination acceptance rates after completion of the COVID-19 vaccination series among historical influenza vaccine refusers.", "datePublished": "2023-07-03", "url": "https://recherchemedicale.com/article/37414694", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2023.06.090" } }, { "@type": "ScholarlyArticle", "name": "Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.", "datePublished": "2023-08-24", "url": "https://recherchemedicale.com/article/37616221", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0281566" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://recherchemedicale.com/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://recherchemedicale.com/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://recherchemedicale.com/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins antiviraux", "item": "https://recherchemedicale.com/mesh/D014765" }, { "@type": "ListItem", "position": 6, "name": "Vaccins contre le SIDA", "item": "https://recherchemedicale.com/mesh/D016915" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins contre le SIDA - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins contre le SIDA", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins contre le SIDA", "description": "Comment évaluer l'efficacité d'un vaccin contre le SIDA ?\nQuels tests sont utilisés pour diagnostiquer le VIH ?", "url": "https://recherchemedicale.com/mesh/D016915?mesh_terms=Influenza+Vaccines#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins contre le SIDA", "description": "Quels sont les symptômes du VIH/SIDA ?\nLe vaccin peut-il provoquer des symptômes ?", "url": "https://recherchemedicale.com/mesh/D016915?mesh_terms=Influenza+Vaccines#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins contre le SIDA", "description": "Comment les vaccins contribuent-ils à la prévention du SIDA ?\nQuelles autres méthodes préviennent le VIH ?", "url": "https://recherchemedicale.com/mesh/D016915?mesh_terms=Influenza+Vaccines#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins contre le SIDA", "description": "Les vaccins remplacent-ils les traitements antirétroviraux ?\nQuels traitements sont disponibles pour le VIH ?", "url": "https://recherchemedicale.com/mesh/D016915?mesh_terms=Influenza+Vaccines#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins contre le SIDA", "description": "Quelles complications peuvent survenir sans vaccin ?\nLes vaccins peuvent-ils causer des complications ?", "url": "https://recherchemedicale.com/mesh/D016915?mesh_terms=Influenza+Vaccines#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins contre le SIDA", "description": "Quels sont les facteurs de risque pour le VIH ?\nLes vaccins réduisent-ils les facteurs de risque ?", "url": "https://recherchemedicale.com/mesh/D016915?mesh_terms=Influenza+Vaccines#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité d'un vaccin contre le SIDA ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des essais cliniques mesurant la réduction des infections." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour diagnostiquer le VIH ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et les tests d'acide nucléique détectent le VIH dans le sang." } }, { "@type": "Question", "name": "Quels sont les symptômes du VIH/SIDA ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, fatigue, éruptions cutanées et infections opportunistes." } }, { "@type": "Question", "name": "Le vaccin peut-il provoquer des symptômes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires légers comme douleur au site d'injection peuvent survenir." } }, { "@type": "Question", "name": "Comment les vaccins contribuent-ils à la prévention du SIDA ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils stimulent le système immunitaire pour prévenir l'infection par le VIH." } }, { "@type": "Question", "name": "Quelles autres méthodes préviennent le VIH ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation de préservatifs et la prophylaxie pré-exposition (PrEP) sont efficaces." } }, { "@type": "Question", "name": "Les vaccins remplacent-ils les traitements antirétroviraux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins complètent les traitements, mais ne les remplacent pas." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le VIH ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les antirétroviraux qui contrôlent la charge virale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans vaccin ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Sans vaccin, le risque d'infections opportunistes et de maladies graves augmente." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils causer des complications ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des complications graves sont rares, mais des réactions allergiques peuvent survenir." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour le VIH ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les rapports non protégés, le partage de seringues et les antécédents d'infections sont des risques." } }, { "@type": "Question", "name": "Les vaccins réduisent-ils les facteurs de risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en prévenant l'infection, les vaccins diminuent les comportements à risque associés." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 27/12/2024

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Jianzhou Yang

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive Medicine, Changzhi Medical College, Changzhi, China.

Xiangjun Zhang

3 publications dans cette catégorie

Affiliations :
  • Department of Public Health, University of Tennessee, Knoxville, TN, United States.

Xiaojie Huang

3 publications dans cette catégorie

Affiliations :
  • Beijing Youan Hospital, Capital Medical University, Beijing, China.

Maohe Yu

3 publications dans cette catégorie

Affiliations :
  • Tianjin Centers for Disease Control and Prevention, Tianjin, China.

Guanghua Lan

3 publications dans cette catégorie

Affiliations :
  • Guangxi Center for Disease Prevention and Control, Nanning, China.

Ying Qiao

3 publications dans cette catégorie

Affiliations :
  • The Second Hospital of Huhhot, Huhhot, China.

Junjie Xu

3 publications dans cette catégorie

Affiliations :
  • Clinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.

Pepijn van Empelen

2 publications dans cette catégorie

Affiliations :
  • Netherlands Organization for Applied Scientific Research (TNO), Expertise Group Child Health, Leiden, Netherlands.

Mohit Chawla

2 publications dans cette catégorie

Affiliations :
  • Physical Sciences and Engineering Division, Kaust Catalysis Center, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.

Chonticha Suwattanasophon

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.

Kiattawee Choowongkomon

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.

Abdul Rajjak Shaikh

2 publications dans cette catégorie

Affiliations :
  • Department of Research and Innovation, STEMskills Research and Education Lab Private Limited, Faridabad, Haryana, India.

Luigi Cavallo

2 publications dans cette catégorie

Affiliations :
  • Physical Sciences and Engineering Division, Kaust Catalysis Center, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.

Subhra Chakraborty

2 publications dans cette catégorie

Affiliations :
  • Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: schakr11@jhu.edu.

Yan Yao

2 publications dans cette catégorie

Affiliations :
  • Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.

Ruiyu Chai

2 publications dans cette catégorie

Affiliations :
  • Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.

Geng-Feng Fu

2 publications dans cette catégorie

Affiliations :
  • Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.

Qidi Zhou

2 publications dans cette catégorie

Affiliations :
  • Department of Emergency Medicine, Shenzhen Hospital, Peking University, Shenzhen, China.

Shuyue Li

2 publications dans cette catégorie

Affiliations :
  • Changchun Maternity Hospital, Changchun, China.

Yulia Gendler

2 publications dans cette catégorie

Affiliations :
  • The Department of Nursing, School of Health Sciences, Ariel University, Ariel 40700, Israel.

Sources (10000 au total)

Global influenza vaccination rates and factors associated with influenza vaccination.

Influenza vaccination is an effective method for preventing influenza virus infection. Herein, we performed a meta-analysis to quantify global influenza vaccination rates (IVRs) and the factors influe... Related articles were obtained from online databases and screened according to the inclusion criteria. The pooled IVRs were calculated using the random effects model. Subgroup analyses and multivariat... We included 522 studies from 68 countries/regions. Most studies were conducted in the European region (247 studies), followed by the Western Pacific (135 studies) and American regions (100 studies). T... Overall, global IVRs were low, especially in the general population. The studies on the IVRs, especially for priority populations, should be strengthened in Eastern Mediterranean, South-East Asian, an...

Association Between Influenza Vaccination During Pregnancy and Infant Influenza Vaccination.

To examine the association between influenza vaccination during pregnancy and infant influenza vaccination.... We conducted a retrospective analysis of individuals aged 15-49 years who were continually privately insured from August 2017 to May 2019 and had singleton live births between September 2017 and Febru... Of the 34,919 pregnant people in this analysis, 14,168 (40.6%) received influenza vaccination during pregnancy. Of the infants born to people vaccinated during pregnancy, 90.0% received at least one d... Our results show a positive and statistically significant relationship between influenza vaccination during pregnancy and infant influenza vaccination status in their first season eligible for vaccina...

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate.

The highdose quadrivalent influenza vaccine (QIVHD) has shown improved protection against influenza and its complications in older adults. We aimed to evaluate the costeffectiveness of QIVHD compared ...

Veteran influenza vaccination acceptance rates after completion of the COVID-19 vaccination series among historical influenza vaccine refusers.

Vaccine hesitancy remains an obstacle in disease prevention. The recent COVID-19 pandemic highlighted this issue and may influence acceptance of other recommended immunizations. The objective of this ... Influenza vaccination acceptance rates for the 2021-2022 influenza season were compared in patients who historically declined the influenza vaccine and either received or declined COVID-19 vaccination... A higher proportion of patients who had received the COVID-19 vaccination(s) subsequently accepted the influenza vaccination compared to the control group (37% vs. 11%, OR = 5.03; CI 3.15-8.26; p = 0.... Among previous influenza vaccine decliners, those who received COVID-19 vaccination had significantly higher odds of receiving subsequent influenza vaccination....

Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.

One of the newest strategies developed by the Global Influenza Strategy has been to broaden the composition of the current influenza vaccine formulations from trivalent products to quadrivalent produc...

Promotion of Influenza Vaccination in the Emergency Department.

Influenza vaccine uptake is low among underserved populations whose primary health care access occurs in emergency departments. We sought to determine whether implementation of two interventions would... This three-group, prospective, cluster-randomized controlled trial compared two interventions with a control group in noncritically ill, adult patients in the emergency department who were not vaccina... Between October 2022 and February 2023, a total of 767 trial participants were enrolled at six emergency departments in five U.S. cities. Median age was 46 years; 353 (46%) participants were female, 2... Implementation of influenza vaccine messaging platforms (video clips, printed materials, and verbal scripts) improved 30-day vaccine uptake among unvaccinated patients in the emergency department. (Fu...

Influenza vaccine and subsequent development of zoster.

Herpes zoster (HZ), which is caused by reactivation of the latent varicella zoster virus, was not listed as a side effect of any vaccines until the introduction of coronavirus disease 2019 (COVID-19) ... This population-based retrospective self-controlled case series evaluated the association between influenza vaccine exposure and HZ risk. Data were collected from Taiwan's National Health Insurance Re... In total, 13,728 patients were diagnosed with HZ before and after receiving the influenza vaccine. The IRR for days 1-15 was significantly higher (IRR = 1.11; 95% confidence interval [CI], 1.02-1.20),... There was a slight increase in risk of HZ in people receiving influenza vaccine in the first 1-15 days after vaccination....